88 related articles for article (PubMed ID: 22739154)
1. [Effect of bortezomib and low concentration cytarabine on apoptosis in U937 cell line].
Du X; Jia PM; He C; Du SH; Tong JH; Zhou L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):554-7. PubMed ID: 22739154
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of apoptosis synergistically induced by bortezomib combined with cytarabine in U937 cell line].
He C; DU X; DU SH; Jia PM; Tong JH; Zhou L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1356-60. PubMed ID: 23257432
[TBL] [Abstract][Full Text] [Related]
3. [Effect of bortezomib and arabinoside on proliferation and apoptosis of K562 cell.].
Lu SF; Lu Q
Zhonghua Xue Ye Xue Za Zhi; 2010 Jan; 31(1):42-5. PubMed ID: 20302779
[TBL] [Abstract][Full Text] [Related]
4. [Apoptosis in Jurkat cells induced by bortezomib combined with adriamycin].
Chen JF; Jin J
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):890-3. PubMed ID: 20193325
[TBL] [Abstract][Full Text] [Related]
5. [Effect of PCI-32765 and bortezomib on proliferation and apoptosis of B-cell tumor cell lines and its mechanisms].
Deng Y; Tao SD; Zhang X; He ZM; Chen Y; Deng ZK; Li YY; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1178-82. PubMed ID: 24156429
[TBL] [Abstract][Full Text] [Related]
6. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
7. [Effect of bortezomib on lymphoma cell line CA46 and its relative mechanisms].
Huang HB; Zhan R; Wu SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):919-22. PubMed ID: 20723300
[TBL] [Abstract][Full Text] [Related]
8. [Effect of bortezomib on sensitization of HL-60 cells to TRAIL].
Hu R; Zhang R; Li YC; Yao K; Yang Y; Hou SY; Yang W; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):617-20. PubMed ID: 20561413
[TBL] [Abstract][Full Text] [Related]
9. [Effects of triptolide on bortezomib-induced apoptosis in multiple myeloma cells].
Yang Y; Dong HJ; Gao GX; Wang YW; Gu HT; Chen XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):335-8. PubMed ID: 22541093
[TBL] [Abstract][Full Text] [Related]
10. [Apoptosis of myeloid leukemia cell line HL60 induced by Bortezomib, a proteasome inhibitor].
Fu YB; Sun QX; Meng FY; Xie J; Zhou GB
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2413-6. PubMed ID: 17156654
[TBL] [Abstract][Full Text] [Related]
11. Bortezomib therapeutic effect is associated with expression and mutation of FGFR3 in human lymphoma cells.
Zheng W; Guan M; Zhu L; Cai Z; Chung V; Huang H; Yen Y
Anticancer Res; 2010 Jun; 30(6):1921-30. PubMed ID: 20651335
[TBL] [Abstract][Full Text] [Related]
12. [Effect of proteasome inhibitor bortezomib on proliferation, apoptosis and SHIP gene expression in K562 cells].
Jia ZQ; Wei YT; Li AM; Cheng ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):916-9. PubMed ID: 23998585
[TBL] [Abstract][Full Text] [Related]
13. [The Effects and Regulatory Mechanism of Targeting CXC Chemokine Receptor 1/2 Combined with Ara-C on the Malignant Biological Behaviors of U937 Cells of Acute Myeloid Leukemia].
Liu YQ; Shen JZ; Yin Y; Chen YT; Yang H; Tang HW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):364-376. PubMed ID: 37096507
[TBL] [Abstract][Full Text] [Related]
14. [Effect of curcumin in combination with bortezomib on proliferation and apoptosis of human multiple myeloma cell line H929 and its mechanism].
Zhang XY; Bai QX; Huang GS; Zhao H; Chen JJ; Yang LJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):684-8. PubMed ID: 21729550
[TBL] [Abstract][Full Text] [Related]
15. A synergistic increase of apoptosis utilizing Fas antigen expression induced by low doses of anticancer drug.
Akiyama H; Ino T; Tokunaga E; Katsuda I; Ezaki K
Rinsho Byori; 2003 Aug; 51(8):733-9. PubMed ID: 13677932
[TBL] [Abstract][Full Text] [Related]
16. The bortezomib-induced mitochondrial damage is mediated by accumulation of active protein kinase C-delta.
Durrant D; Liu J; Yang HS; Lee RM
Biochem Biophys Res Commun; 2004 Sep; 321(4):905-8. PubMed ID: 15358112
[TBL] [Abstract][Full Text] [Related]
17. [Effect of proteasome inhibitor bortezomib on proliferation, apoptosis and XIAP expression in K562 cells].
Shao M; Sun L; Cui XY; Han XF; Chen SM; Wang F; Zhang H; Ling Z
Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):182-6. PubMed ID: 21535957
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status.
Minderman H; Zhou Y; O'Loughlin KL; Baer MR
Cancer Chemother Pharmacol; 2007 Jul; 60(2):245-55. PubMed ID: 17096161
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
Wang Z; Van Tuyle G; Conrad D; Fisher PB; Dent P; Grant S
Cancer Res; 1999 Mar; 59(6):1259-67. PubMed ID: 10096557
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]